Juno Therapeutics

About:

Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.

Website: http://junotherapeutics.com

Twitter/X: junothera

Top Investors: Bezos Expeditions, Alaska Permanent Fund, Venrock, ARCH Venture Partners

Description:

Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs.